Management of a Patient With Subdural Hematoma Complicated by the Presence of Heparin-Induced and Suspected Concomitant Immune Thrombocytopenia: A Case Report

Roza Chaireti, Argyrios Gkasiamis, Tomas L. Lindahl

Abstract


A patient with antiphospholipid syndrome treated with warfarin presented to the emergency department with a traumatic subdural hematoma. Two days following the evacuation of the hematoma, treatment with low molecular weight heparin (LMWH) was initiated. One week later, the patient developed new symptoms. The hematoma had relapsed and the platelet count had decreased considerably. The thrombocytopenia was diagnosed as heparin-induced and the anticoagulant treatment was discontinued. Following increase of the platelet count, treatment with fondaparinux was initiated. However, 1 day following that, the platelet count had decreased again and cross-reaction between the LMWH and fondaparinux was suspected. Due to the risk of hematoma relapse, the patient started treatment with cortisone, responding promptly. The platelet count was stabilized and the patient resumed the treatment with warfarin without complications. The thrombocytopenia was initially heparin-induced and complicated by the cross-reaction between LMWH and fondaparinux as well as the presence of suspected autoimmune thrombocytopenia, as suggested by the response to corticosteroids. This case report illustrates the difficulties in diagnosing and managing thrombocytopenia of complex etiology.




J Hematol. 2015;4(3):202-204
doi: http://dx.doi.org/10.14740/jh219w


Keywords


Thrombocytopenia; Antiphospholipid syndrome; Fondaparinux

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Hematology, quarterly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.

IMPORTANT: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!